Hubei Guangji Pharmaceutical Co Ltd Financial Flexibility Index
Hubei Guangji Pharmaceutical Co Ltd financial flexibility index. Hubei Guangji Pharmaceutical Co Ltd (000952) has a Financial Flexibility Index of 0.02x as of September 2025. Free cash flow of CN¥31.05 Million (operating CF CN¥22.38 Million minus capex CN¥8.67 Million) represents 0% of total liabilities (CN¥1.62 Billion). Explore Hubei Guangji Pharmaceutical Co Ltd (000952) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Hubei Guangji Pharmaceutical Co Ltd (1998–2025)
Financial flexibility index of Hubei Guangji Pharmaceutical Co Ltd from 1998 to 2025. Historical Financial Flexibility Index trend for Hubei Guangji Pharmaceutical Co Ltd across 28 annual periods. Check Hubei Guangji Pharmaceutical Co Ltd (000952) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Hubei Guangji Pharmaceutical Co Ltd Financial Flexibility Index by Year (1998–2025)
Hubei Guangji Pharmaceutical Co Ltd financial flexibility index by year from 1998 to 2025. Year-by-year free cash flow to debt coverage for Hubei Guangji Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see how efficiently does Hubei Guangji Pharmaceutical Co Ltd generate cash.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.06x | CN¥96.07 Million | CN¥60.43 Million | CN¥1.69 Billion | ▼ -37.1% |
| 2024 | 0.09x | CN¥155.59 Million | CN¥655.36K | CN¥1.72 Billion | ▼ -64.4% |
| 2023 | 0.25x | CN¥417.17 Million | CN¥-148.96 Million | CN¥1.64 Billion | ▲ +0.1% |
| 2022 | 0.25x | CN¥248.79 Million | CN¥45.08 Million | CN¥977.25 Million | ▼ -11.7% |
| 2021 | 0.29x | CN¥172.51 Million | CN¥75.91 Million | CN¥598.09 Million | ▼ -18.5% |
| 2020 | 0.35x | CN¥217.27 Million | CN¥119.38 Million | CN¥613.75 Million | ▲ +7.6% |
| 2019 | 0.33x | CN¥263.96 Million | CN¥144.20 Million | CN¥802.21 Million | ▼ -13.2% |
| 2018 | 0.38x | CN¥307.97 Million | CN¥231.44 Million | CN¥812.33 Million | ▲ +28.0% |
| 2017 | 0.30x | CN¥259.74 Million | CN¥178.83 Million | CN¥876.65 Million | ▲ +3.1% |
| 2016 | 0.29x | CN¥280.02 Million | CN¥167.07 Million | CN¥974.70 Million | ▲ +315.2% |
| 2015 | 0.07x | CN¥76.59 Million | CN¥-33.35 Million | CN¥1.11 Billion | ▲ +273.8% |
| 2014 | 0.02x | CN¥19.94 Million | CN¥-74.69 Million | CN¥1.08 Billion | ▼ -89.6% |
| 2013 | 0.18x | CN¥145.20 Million | CN¥95.16 Million | CN¥816.78 Million | ▼ -37.2% |
| 2012 | 0.28x | CN¥225.48 Million | CN¥108.02 Million | CN¥795.93 Million | ▼ -35.6% |
| 2011 | 0.44x | CN¥282.84 Million | CN¥81.88 Million | CN¥643.07 Million | ▲ +24.4% |
| 2010 | 0.35x | CN¥192.74 Million | CN¥77.18 Million | CN¥545.06 Million | ▲ +37.1% |
| 2009 | 0.26x | CN¥125.58 Million | CN¥-24.35 Million | CN¥486.93 Million | ▼ -76.8% |
| 2008 | 1.11x | CN¥440.46 Million | CN¥220.70 Million | CN¥395.78 Million | ▼ -4.8% |
| 2007 | 1.17x | CN¥380.92 Million | CN¥331.98 Million | CN¥325.76 Million | ▲ +148.4% |
| 2006 | 0.47x | CN¥144.68 Million | CN¥125.95 Million | CN¥307.34 Million | ▲ +106.4% |
| 2005 | 0.23x | CN¥79.98 Million | CN¥54.14 Million | CN¥350.68 Million | ▲ +100.3% |
| 2004 | 0.11x | CN¥44.27 Million | CN¥-3.32 Million | CN¥388.76 Million | ▼ -20.3% |
| 2003 | 0.14x | CN¥50.34 Million | CN¥-15.40 Million | CN¥352.38 Million | ▼ -64.7% |
| 2002 | 0.40x | CN¥126.72 Million | CN¥76.20 Million | CN¥313.05 Million | ▲ +355.4% |
| 2001 | 0.09x | CN¥24.44 Million | CN¥-22.40 Million | CN¥274.96 Million | ▼ -76.5% |
| 2000 | 0.38x | CN¥73.67 Million | CN¥48.57 Million | CN¥194.67 Million | ▼ -63.0% |
| 1999 | 1.02x | CN¥204.15 Million | CN¥68.57 Million | CN¥199.49 Million | ▲ +1650.4% |
| 1998 | -0.07x | CN¥-12.33 Million | CN¥-15.29 Million | CN¥186.80 Million | — |